- Home
- JAZZ vs PEGA Comparison
JAZZ vs PEGA Comparison
Compare JAZZ & PEGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAZZ
- PEGA
- Stock Information
- Founded
- JAZZ 2003
- PEGA 1983
- Country
- JAZZ Ireland
- PEGA United States
- Employees
- JAZZ N/A
- PEGA N/A
- Industry
- JAZZ Biotechnology: Pharmaceutical Preparations
- PEGA EDP Services
- Sector
- JAZZ Health Care
- PEGA Technology
- Exchange
- JAZZ Nasdaq
- PEGA Nasdaq
- Market Cap
- JAZZ 6.5B
- PEGA 6.9B
- IPO Year
- JAZZ 2007
- PEGA 1996
- Fundamental
- Price
- JAZZ $122.38
- PEGA $86.61
- Analyst Decision
- JAZZ Buy
- PEGA Buy
- Analyst Count
- JAZZ 14
- PEGA 10
- Target Price
- JAZZ $173.57
- PEGA $85.90
- AVG Volume (30 Days)
- JAZZ 613.8K
- PEGA 645.9K
- Earning Date
- JAZZ 11-06-2024
- PEGA 10-23-2024
- Dividend Yield
- JAZZ N/A
- PEGA 0.14%
- EPS Growth
- JAZZ 458.10
- PEGA N/A
- EPS
- JAZZ 7.04
- PEGA 1.36
- Revenue
- JAZZ $3,992,712,000.00
- PEGA $1,480,583,000.00
- Revenue This Year
- JAZZ $7.43
- PEGA $5.40
- Revenue Next Year
- JAZZ $6.39
- PEGA $7.09
- P/E Ratio
- JAZZ $17.64
- PEGA $66.47
- Revenue Growth
- JAZZ 5.23
- PEGA 9.28
- 52 Week Low
- JAZZ $99.06
- PEGA $44.07
- 52 Week High
- JAZZ $134.17
- PEGA $91.54
- Technical
- Relative Strength Index (RSI)
- JAZZ 59.35
- PEGA 67.59
- Support Level
- JAZZ $108.74
- PEGA $85.13
- Resistance Level
- JAZZ $128.99
- PEGA $91.54
- Average True Range (ATR)
- JAZZ 2.93
- PEGA 1.96
- MACD
- JAZZ 1.13
- PEGA 0.35
- Stochastic Oscillator
- JAZZ 62.86
- PEGA 65.31
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About PEGA Pegasystems Inc.
Founded in 1983, Pegasystems provides a suite of solutions for customer engagement and business process management. The company's key offering is the Pega Infinity platform, which combines business process management, or BPM, with customer relationship management, or CRM, applications. The company focuses on enterprise-size customers, specifically within the financial, insurance, and healthcare fields.